EB
Ensysce Biosciences, Inc.
SEC filingOther Health Care · LA Jolla, CA
Amount raised$77.2Msold at filing
Total offering$77.2M
Investors in the raise44count reported to the SEC
FiledAug 20, 2026first sale Aug 5, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
William Lynn ChangDirector
Bob Lynn GowerDirector
Adam Lynn LevinDirector
D Lynn KirkpatrickExecutive Officer, Director
Steve Lynn MartinDirector
David Lynn HumphreyExecutive Officer
James Lynn MorrisonExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.